1WESTERVELT P,BROWN R A,ADKINS D R,et al.Sudden death among patients with acute promyelocytic leukemia treated with arsenic trioxide[J].Blood,2001,98:266-271. 被引量：1
3UNNIKRISHNAN D,DUTCHER J P,VARSHNEY-A N,et al.Torsadesdepointes in 3 patients with leukemia treated with arsenic trioxide[J].Blood,2001,97:1514-1516. 被引量：1
4HUANG C H,CHEN W J,WU C C,et al.Complete a trioventricular block after arsenic trioxide treatment in an acute promyelocytic leukemia patient[J].Pacing Clin Electrophysiol,2000,22:965-967. 被引量：1
7KEISUKEYAMAZAKI M D,HAJIME TERADA M D,HIROSHI SATOH,et al.Arrhythmogenic effects of arsenic trioxide in patients with acute promyelocytic leukemia and an electrophysiological study in isolated guinea pig papillary muscles[J].Circ J,2006,70:1407-1414. 被引量：1
5Germanakis I, Kalmanti M, Parthenakis F, et al. Correlation of plasma N-terminal pro-brain natriuretic peptide level with left ventricle mass in children treated with anthracyclines[ J]. Int J Cardiol,2006,108:212 -215. 被引量：1
6Malty M, Espie M, Llombart A, et al. Muhicenter randomized Phase Ⅲ study of the cardioprotective effect of dexrazoxane in advanced/metastatic breast cancer patients treated with anthracycline-based chemotherapy[ J]. Ann Onco1,2006 ,17 :614 - 622. 被引量：1
7Sterba M, Popelova O, Simunek T, et al. Iron chelation-afforded cardioprotection against chronic anthracycline cardiotoxicity: a study of salicylaldehyde isonicotinoyl hydrazone (SIH) [ J ]. Toxicology ,2007,253 ( 3 ) : 150 - 166. 被引量：1
8Kaiserva H, Simunek T, van der Vijgh W J, et al. Flavonoids as protectors against doxorubicin cardiotoxicity : role of iron chelation, an-tioxidant activity and inhibition of carbonyl reductase [ J ]. Biochim Biophys Acta,2007,1772 : 1065 - 1074. 被引量：1
9Takemura G, Fujiwara H. Doxorubicin-induced cardiomyopathy from the eardiotoxic mechanisms to management[ J], Prag Cardiovase Dis,2007,49 (5) :330 - 352. 被引量：1
10Saad SY, Najjar TA, Arafah MM. Cardioprotective effects of subcutaneous ebselen against daunorubicin-induced cardimyopathy in rats [ J ]. Basic Clin Pharmacol Toxico1,2006,99 (6) :412 - 417. 被引量：1
